Jacques Lapointe

6.0k total citations · 1 hit paper
127 papers, 4.8k citations indexed

About

Jacques Lapointe is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacques Lapointe has authored 127 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 22 papers in Genetics and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacques Lapointe's work include RNA and protein synthesis mechanisms (72 papers), RNA modifications and cancer (44 papers) and Bacterial Genetics and Biotechnology (20 papers). Jacques Lapointe is often cited by papers focused on RNA and protein synthesis mechanisms (72 papers), RNA modifications and cancer (44 papers) and Bacterial Genetics and Biotechnology (20 papers). Jacques Lapointe collaborates with scholars based in Canada, United States and France. Jacques Lapointe's co-authors include Jonathan R. Pollack, James D. Brooks, Daniel Kern, Chunde Li, Dieter Söll, Matt van de Rijn, Sheng‐Xiang Lin, Michelle Ferrari, Paul H. Roy and Julian P. T. Higgins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Jacques Lapointe

127 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

2004 984 citations Jacques Lapointe, Chunde Li et al. profile →

Peers

Countries citing papers authored by Jacques Lapointe

Since Specialization

Citations

This map shows the geographic impact of Jacques Lapointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Lapointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Lapointe more than expected).

Fields of papers citing papers by Jacques Lapointe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Lapointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Lapointe. The network helps show where Jacques Lapointe may publish in the future.

Co-authorship network of co-authors of Jacques Lapointe

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Lapointe. A scholar is included among the top collaborators of Jacques Lapointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Lapointe. Jacques Lapointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification–Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples 2020 ·Journal of Molecular Diagnostics ·Walead Ebrahimizadeh, Karl‐Philippe Guérard, (unknown), (unknown), Eleonora Scarlata, Fadi Brimo, Palak Patel, Tamara Jamaspishvili, Armen Aprikian, David M. Berman, John M.S. Bartlett, Simone Chevalier, Jacques Lapointe	5
2	Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer 2019 ·Cancer Cell International ·Elie Akoury, Pouyan Ahangar, (unknown), Jacques Lapointe, Karl‐Philippe Guérard, Lisbet Haglund, Derek H. Rosenzweig, Michael H. Weber	14
3	Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores 2017 ·PLoS ONE ·Palak Patel, Shamini Selvarajah, Karl‐Philippe Guérard, John M.S. Bartlett, Jacques Lapointe, David M. Berman, John B. A. Okello, Paul C. Park	52
4	Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer 2017 ·Genes & Development ·Étienne Audet‐Walsh, Catherine R. Dufour, Tracey Yee, (unknown), Ming Yan, (unknown), Mathieu Vernier, Maxime Caron, Guillaume Bourque, Eleonora Scarlata, Lucie Hamel, Fadi Brimo, Armen Aprikian, Jacques Lapointe, Simone Chevalier, Vincent Giguère	98
5	Cyclic peptides identified by phage display are competitive inhibitors of the tRNA-dependent amidotransferase of Helicobacter pylori 2016 ·Peptides ·(unknown), Halim Maaroufi, Roger C. Lévesque, Jacques Lapointe	4
6	Inhibition of Helicobacter pylori aminoacyl-tRNA amidotransferase by chloramphenicol analogs 2010 ·Bioorganic & Medicinal Chemistry ·(unknown), Maria De Mieri, Jonathan L. Huot, Sébastien P. Blais, Jacques Lapointe, Robert Chênevert	20
7	Peculiar inhibition of human mitochondrial aspartyl-tRNA synthetaseby adenylate analogs 2009 ·Biochimie ·Marie C. Messmer, Sébastien P. Blais, (unknown), Robert Chênevert, (unknown), Patrick Lagüe, C. Sauter, Marie Sissler, Richard Giegé, Jacques Lapointe, Catherine Florentz	19
8	Identification of candidate prostate cancer genes through comparative expression‐profiling of seminal vesicle 2008 ·The Prostate ·Maxwell Thompson, Jacques Lapointe, Yoon‐La Choi, David E. Ong, Julian P. T. Higgins, James D. Brooks, Jonathan R. Pollack	21
9	hCAP-D3 Expression Marks a Prostate Cancer Subtype With Favorable Clinical Behavior and Androgen Signaling Signature 2008 ·The American Journal of Surgical Pathology ·Jacques Lapointe, (unknown), Julian P. T. Higgins, Eric Bair, Maxwell Thompson, Keyan Salari, Craig P. Giacomini, Michelle Ferrari, Kelli Montgomery, Robert Tibshirani, Matt van de Rijn, James D. Brooks, Jonathan R. Pollack	28
10	Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis 2007 ·Cancer Research ·Jacques Lapointe, Chunde Li, Craig P. Giacomini, Keyan Salari, Stephanie Huang, Pei Wang, Michelle Ferrari, Tina Hernandez‐Boussard, James D. Brooks, Jonathan R. Pollack	190
11	The Retinoic Acid Synthesis Gene ALDH1a2 Is a Candidate Tumor Suppressor in Prostate Cancer 2005 ·Cancer Research ·Hanna Kim, Jacques Lapointe, Gülşah Kaygusuz, David E. Ong, Chunde Li, Matt van de Rijn, James D. Brooks, Jonathan R. Pollack	110
12	Glutamylsulfamoyladenosine and pyroglutamylsulfamoyladenosine are competitive inhibitors of E. coli glutamyl-tRNA synthetase 2005 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Jacques Lapointe, Robert Chênevert	19
13	Glu-Q-tRNAAsp synthetase coded by the yadB gene, a new paralog of aminoacyl-tRNA synthetase that glutamylates tRNAAsp anticodon 2005 ·Biochimie ·Mickaël Blaise, H. D. Becker, Jacques Lapointe, Christian Cambillau, Richard Giegé, Daniel Kern	31
14	The Escherichia coli YadB Gene Product Reveals a Novel Aminoacyl-tRNA Synthetase Like Activity 2004 ·Journal of Molecular Biology ·Valérie Campanacci, (unknown), H. D. Becker, Daniel Kern, Silvia Spinelli, C. Alexander Valencia, (unknown), (unknown), Sacha Grisel, Renaud Vincentelli, Christophe Bignon, Jacques Lapointe, Richard Giegé, Christian Cambillau	46
15	Role of the Cyclin-Dependent Kinase Inhibitor p27^Kip1in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation 2001 ·Endocrinology ·Jacques Lapointe, Claude Labrie	29
16	Identification and Cloning of a Novel Androgen-Responsive Gene, Uridine Diphosphoglucose Dehydrogenase, in Human Breast Cancer Cells1 1999 ·Endocrinology ·Jacques Lapointe, Claude Labrie	16
17	Effect of modified nucleotides on Escherichia coli tRNA^Glu structure and on its aminoacylation by glutamyl‐tRNA synthetase 1999 ·European Journal of Biochemistry ·Éric Madore, Catherine Florentz, Richard Giegé, Shun‐ichi Sekine, Shigeyuki Yokoyama, Jacques Lapointe	88
18	Prognostic implications of a negative dipyridamole-thallium scan: Results in 360 patients 1992 ·The American Journal of Medicine ·Jean Lette, David D. Waters, Patrick Champagne, Michel Picard, Michel Cerino, Jacques Lapointe	6
19	Precise mapping and comparison of two evolutionarily related regions of the Escherichia coli K-12 chromosome 1990 ·Journal of Molecular Biology ·Yves V. Brun, Rock Breton, (unknown), Jacques Lapointe	18
20	Purification and partial amino acid sequence of a glutamyl-tRNA synthetase from Rhizobium meliloti 1989 ·Biochemistry and Cell Biology ·Serge Laberge, Manon Bélair, Alain Verreault, (unknown), L. M. Bordeleau, Jacques Lapointe	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact